Anhui Tongling Bionic Technology Co.

Medical Devices & EquipmentSeries BHefei, Chinatelelife.com.cn

Latest round

Series B

Last raised

Jul 2022

Total raised

Undisclosed

Investors

2

About Anhui Tongling Bionic Technology Co.

, dba TeleLife, is a medical device company focused on the development, production and sales of cardiopulmonary assisted medical devices. The company's chairman and general manager, Dr. Qilian Xie, is a postdoctoral fellow at the National Heart and Lung Institute of Imperial College, with more than 20 years of cardiovascular and critical care clinical experience, more than 80 domestic and international academic papers, and more than 60 domestic and international invention patents. The company has more than 100 independent innovation patents as of 2022. The company's main business is the research and development, production and sales of cardiopulmonary assisted medical devices. The company's self-developed innovative products include intra-aortic balloon pump (IABP), extracorporeal counterpulsation therapy system, non-invasive cardiac output monitor and extracorporeal membrane oxygenation equipment (ECMO). The company generates revenue from the sales of medical devices., Ltd.

Who invested in Anhui Tongling Bionic Technology Co.

2 investors across 2 rounds

See all investors in Anhui Tongling Bionic Technology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 19, 2022

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Apr 9, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Anhui Tongling Bionic Technology Co.

Who invested in Anhui Tongling Bionic Technology Co.?

Anhui Tongling Bionic Technology Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Anhui Tongling Bionic Technology Co. raised?

Anhui Tongling Bionic Technology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Anhui Tongling Bionic Technology Co. last raise money?

Anhui Tongling Bionic Technology Co.'s most recent round on record is a Series B, in Jul 2022.

What does Anhui Tongling Bionic Technology Co. do?

, dba TeleLife, is a medical device company focused on the development, production and sales of cardiopulmonary assisted medical devices.

Where is Anhui Tongling Bionic Technology Co. headquartered?

Anhui Tongling Bionic Technology Co. is headquartered in Hefei, China.

Which VCs invest in companies like Anhui Tongling Bionic Technology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Anhui Tongling Bionic Technology Co.'s stage. Their profiles are linked below.

Raising like Anhui Tongling Bionic Technology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.